Key result
Antidepressants, combination therapy, and exercise yielded the strongest effects on depressive symptoms at 8 weeks in patients with CAD, with all treatments being equally acceptable.
Why the study?
Depression is common and linked to poor outcomes in CAD, but it is unclear which depression treatments are most effective or acceptable to patients.
Do depression treatments improve depressive symptoms in patients with coronary artery disease?
Meta-Analysis (n=7,240)
Do depression treatments improve depressive symptoms in patients with coronary artery disease?
Antidepressants have the most robust evidence base for treating post-CAD depression, though combination therapy and exercise show promise.
Supports antidepressants, exercise, or combination as preferred options for depression in CAD; extends evidence via comprehensive network synthesis.
OBJECTIVE: Depression is common in patients with coronary artery disease (CAD) and is associated with poor outcomes. Although different treatments are available, it is unclear which are best or most acceptable to patients, so we conducted a network meta-analysis of evidence from randomized controlled trials (RCTs) of different depression treatments to ascertain relative efficacy. METHODS: We searched for systematic reviews of RCTs of depression treatments in CAD and updated these with a comprehensive search for recent individual RCTs. RCTs comparing depression treatments (pharmacological, psychotherapeutic, combined pharmacological/psychotherapeutic, exercise, collaborative care) were included. Primary outcomes were acceptability (dropout rate) and change in depressive symptoms 8 week after treatment commencement. Change in 26-week depression and mortality were secondary outcomes. Frequentist, random-effects network meta-analysis was used to synthesize the evidence, and evidence quality was evaluated following Grading of Recommendations, Assessment, Development and Evaluations recommendations. RESULTS: Thirty-three RCTs (7240 participants) provided analyzable data. All treatments were equally acceptable. At 8 weeks, combination therapy (1 study), exercise (1 study), and antidepressants (10 studies) yielded the strongest effects versus comparators. At 26 weeks, antidepressants were consistently effective, but psychotherapy was only effective versus usual care. There were no differences in treatment groups for mortality. Grading of Recommendations, Assessment, Development and Evaluations ratings ranged from very low to low. CONCLUSIONS: Overall, the evidence was limited and biased. Although all treatments for post-CAD depression were equally acceptable, antidepressants have the most robust evidence base and should be the first-line treatment. Combinations of antidepressants and psychotherapy, along with exercise, could be more effective than antidepressants alone but require further rigorous, multiarm intervention trials.Systematic Review Registration: CRD42018108293 (International Prospective Register of Systematic Reviews).
No takes yet. Share an insight, caveat, or question.
Doyle et al. (2021) conducted a meta-analysis in Depressive symptoms in patients with coronary artery disease (n=7,240). Depression treatments (pharmacological, psychotherapeutic, combined, exercise, collaborative care) vs. Comparators (including usual care) was evaluated on Acceptability (dropout rate) and change in depressive symptoms 8 weeks after treatment commencement. Antidepressants, combination therapy, and exercise yielded the strongest effects on depressive symptoms at 8 weeks in patients with CAD, with all treatments being equally acceptable.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: